Cardiac rhythm management (CRM) is the treatment of arrhythmias (heart rhythm disorders) or atrial fibrillation (AF). Arrhythmias can cause a range of problems for patients, from palpitations and dizzy spells to sudden cardiac arrest. Cardiac rhythm management devices such as pacemakers, cardiac resynchronization therapy (CRT) devices and implantable cardiac defibrillators (ICDs) continue to evolve rapidly in reliability and lifespan. Most CRM devices are implanted under the skin, with one to three leads threaded down a vein to connect to the heart.
Market Dynamics
Increasing incidences of heart failure and arrhythmia have fuelled rapid advancements in cardiac rhythm management (CRM) technologies eventually increasing the demand for CRM devices. According to the study published in 2016, by the Journal of the Formosan Medical Association, around 72 million people are estimated to suffer from atrial fibrillation in Asia by 2050, which is expected to be more than double the combined numbers of patients from the U.S. and Europe.
However, factors such as chances of infections associated with installation of pacemakers in cardiac patients can hamper the cardiac rhythm management devices market growth. Pacemaker surgery can also led to various complications such as bleeding, bruising or swelling at the of area of pacemaker implantation leading to blood vessel or nerve damage, which in turn can reduce adoption of cardiac implants in patients.
Key features of the study:
- This report provides in-depth analysis of the cardiac rhythm management devices market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global cardiac rhythm management devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Medtronic plc, Abbott Laboratories, Abiomed, Boston Scientific Corporation, Biotronik Se Co Kg, Koninklijke Philips N.V., LivaNova Plc, Cardiac Science Corporation, Schiller Ag, and Zoll Medical Corporation
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global cardiac rhythm management devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for cardiac rhythm management devices market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Cardiac Rhythm Management Devices Market, By Product Type:
- Cardiac Resynchronization Therapy Devices
- Cardiac Resynchronization Therapy Defibrillators (CRT-D)
- Cardiac Resynchronization Therapy Pacemakers (CRT-P)
- Defibrillator
- Implantable Cardioverter Defibrillators (ICDS)
- External Defibrillators
- Pacemakers
- Single Chamber Pacemakers
- Dual Chamber Pacemakers
- Biventricular Pacemakers
- Global Cardiac Rhythm Management Devices Market, By End User:
- Hospital
- Home Care Settings
- Ambulatory Care Settings
- Global Cardiac Rhythm Management Devices Market, By Region:
- North America
- By Country:
- By Product Type:
- Cardiac Resynchronization Therapy Devices
- Cardiac Resynchronization Therapy Defibrillators (CRT-D)
- Cardiac Resynchronization Therapy Pacemakers (CRT-P)
- Defibrillator
- Implantable Cardioverter Defibrillators (ICDS)
- External Defibrillators
- Pacemakers
- Single Chamber Pacemakers
- Dual Chamber Pacemakers
- Biventricular Pacemakers
- By End User:
- Hospital
- Home Care Settings
- Ambulatory Care Settings
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- By Product Type:
- Cardiac Resynchronization Therapy Devices
- Cardiac Resynchronization Therapy Defibrillators (CRT-D)
- Cardiac Resynchronization Therapy Pacemakers (CRT-P)
- Defibrillator
- Implantable Cardioverter Defibrillators (ICDS)
- External Defibrillators
- Pacemakers
- Single Chamber Pacemakers
- Dual Chamber Pacemakers
- Biventricular Pacemakers
- By End User:
- Hospital
- Home Care Settings
- Ambulatory Care Settings
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- By Product Type:
- Cardiac Resynchronization Therapy Devices
- Cardiac Resynchronization Therapy Defibrillators (CRT-D)
- Cardiac Resynchronization Therapy Pacemakers (CRT-P)
- Defibrillator
- Implantable Cardioverter Defibrillators (ICDS)
- External Defibrillators
- Pacemakers
- Single Chamber Pacemakers
- Dual Chamber Pacemakers
- Biventricular Pacemakers
- By End User:
- Hospital
- Home Care Settings
- Ambulatory Care Settings
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Product Type:
- Cardiac Resynchronization Therapy Devices
- Cardiac Resynchronization Therapy Defibrillators (CRT-D)
- Cardiac Resynchronization Therapy Pacemakers (CRT-P)
- Defibrillator
- Implantable Cardioverter Defibrillators (ICDS)
- External Defibrillators
- Pacemakers
- Single Chamber Pacemakers
- Dual Chamber Pacemakers
- Biventricular Pacemakers
- By End User:
- Hospital
- Home Care Settings
- Ambulatory Care Settings
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- By Product Type:
- Cardiac Resynchronization Therapy Devices
- Cardiac Resynchronization Therapy Defibrillators (CRT-D)
- Cardiac Resynchronization Therapy Pacemakers (CRT-P)
- Defibrillator
- Implantable Cardioverter Defibrillators (ICDS)
- External Defibrillators
- Pacemakers
- Single Chamber Pacemakers
- Dual Chamber Pacemakers
- Biventricular Pacemakers
- By End User:
- Hospital
- Home Care Settings
- Ambulatory Care Settings
- Africa
- By Country:
- South Africa
- Central Africa
- North Africa
- By Product Type:
- Cardiac Resynchronization Therapy Devices
- Cardiac Resynchronization Therapy Defibrillators (CRT-D)
- Cardiac Resynchronization Therapy Pacemakers (CRT-P)
- Defibrillator
- Implantable Cardioverter Defibrillators (ICDS)
- External Defibrillators
- Pacemakers
- Single Chamber Pacemakers
- Dual Chamber Pacemakers
- Biventricular Pacemakers
- By End User:
- Hospital
- Home Care Settings
- Ambulatory Care Settings
- Company Profiles
- Medtronic plc*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Abbott Laboratories
- Abiomed
- Boston Scientific Corporation
- Biotronik Se Co Kg
- Koninklijke Philips N.V.
- LivaNova Plc
- Cardiac Science Corporation
- Schiller Ag
- Zoll Medical Corporation
“*” marked represents similar segmentation in other categories in the respective section.
